Drugs / hMG-IBSA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00335894 | May 2005 → May 2008 | infertility disorder | IBSA Institut Biochimique SA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hMG-IBSA | “one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa)” NCT00335894 ↗ |
| Known as | hMG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00335894 ↗ |
| Route | Subcutaneous | “two different subcutaneous hMG preparations (hMG-IBSA, IBSA vs Menopur, Ferring Pharmaceuticals, Inc.)” NCT00335894 ↗ |